Krystal Biotech News

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Krystal Biotech (KRYS) and Veeva Systems (VEEV)

TipRanksMay 31 20:10

HC Wainwright & Co. : The Krystal Biotech (KRYS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $200.00.

Zhitong FinanceMay 8 23:50

Krystal Biotech Analyst Ratings

BenzingaMay 8 23:45

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target

BenzingaMay 8 23:46

HC Wainwright & Co. : The Krystal Biotech (KRYS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $200.00.

Zhitong FinanceMay 7 01:50

Krystal Biotech Analyst Ratings

BenzingaMay 7 01:47

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target

BenzingaMay 7 01:48

Maintaining Buy Rating on Krystal Biotech: Strong VYJUVEK Sales and Promising Pipeline Despite EPS Miss

TipRanksMay 6 23:15

HC Wainwright & Co. : The Krystal Biotech (KRYS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $200.00.

Zhitong FinanceApr 23 01:50

Krystal Biotech Analyst Ratings

BenzingaApr 23 01:47

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $200 Price Target

BenzingaApr 23 01:48

Krystal Biotech Analyst Ratings

BenzingaApr 16 20:20

Krystal Biotech Analyst Ratings

BenzingaFeb 28 01:14

Buy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity

TipRanksFeb 27 09:35

Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS)

TipRanksJan 25 20:26

Krystal Biotech Analyst Ratings

BenzingaDec 13, 2023 23:29

Goldman Sachs Initiates Coverage On Krystal Biotech With Buy Rating, Announces Price Target of $160

BenzingaNov 20, 2023 18:01

Krystal Biotech Analyst Ratings

BenzingaNov 20, 2023 17:59

Cantor Fitzgerald Reiterates Overweight on Krystal Biotech, Maintains $160 Price Target

BenzingaNov 8, 2023 00:53

Krystal Biotech Analyst Ratings

BenzingaNov 8, 2023 00:52